Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response

Cancer Immunology, Immunotherapy

Volumn 59, Issue 3, 2010, Pages 419-429

  Alzabin, Saba ^a,b   Pyarajan, Saiju ^a,c   Yee, Herman ^a   Kiefer, Friedemann ^d   Suzuki, Akira ^e   Burakoff, Steven ^a,c   Sawasdikosol, Sansana ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^e AKITA UNIVERSITY   (Japan)

Author keywords

Immunosuppression; Lung cancer; Prostaglandin E2; T cell; Tumor immunology

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; HEMATOPOIETIC PROGENITOR KINASE 1; INTERLEUKIN 2; PROSTAGLANDIN E2; PROTEIN SERINE THREONINE KINASE; SC 791; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

ANIMALS; CARCINOMA, LEWIS LUNG; DINOPROSTONE; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 73349091816     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0761-0     Document Type: Article

References (43)

1. R Arnold IM Patzak B Neuhaus S Vancauwenbergh A Veillette J Van Lint F Kiefer 2005 Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1 Mol Cell Biol 25 2364 2383 10.1128/MCB.25.6.2364-2383.2005 1:CAS:528:DC%2BD2MXisVOiur0%3D 15743830 (Pubitemid 40354631)
2. M Azuma D Ito H Yagita K Okumura JH Phillips LL Lanier C Somoza 1993 B70 antigen is a second ligand for CTLA-4 and CD28 Nature 366 76 79 10.1038/366076a0 1:CAS:528:DyaK2cXivVymtQ%3D%3D 7694153 (Pubitemid 23345240)
3. JG Bode A Nimmesgern J Schmitz F Schaper M Schmitt W Frisch D Haussinger PC Heinrich L Graeve 1999 LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages FEBS Lett 463 365 370 10.1016/S0014-5793(99)01662-2 1:CAS:528:DyaK1MXnvFemtLo%3D 10606755 (Pubitemid 30001952)
4. D Brenner A Golks M Becker W Muller CR Frey R Novak D Melamed F Kiefer PH Krammer R Arnold 2007 Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes Blood 110 3968 3977 10.1182/blood-2007-01-071167 1:CAS:528:DC%2BD2sXhtl2qsb7F 17712048 (Pubitemid 350248452)
5. D Brenner A Golks F Kiefer PH Krammer R Arnold 2005 Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death EMBO J 24 4279 4290 10.1038/sj.emboj.7600894 1:CAS:528: DC%2BD2MXhtlanu7zE 16341093 (Pubitemid 41828903)
6. S Chell A Kaidi AC Williams C Paraskeva 2006 Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer Biochim Biophys Acta 1766 104 119 1:CAS:528:DC%2BD28XotVyru74%3D 16859832
7. JY Chiang IK Jang R Hodes H Gu 2007 Ablation of Cbl-b provides protection against transplanted and spontaneous tumors J Clin Invest 117 1029 1036 10.1172/JCI29472 1:CAS:528:DC%2BD2sXktVOitrc%3D 17364027 (Pubitemid 46556759)
8. S Chouaib K Welte R Mertelsmann B Dupont 1985 Prostaglandin E2 acts at two distinct pathways of T-lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression J Immunol 135 1172 1179 1:CAS:528:DyaL2MXltFKqurw%3D 2989362
9. GP Dunn LJ Old RD Schreiber 2004 The immunobiology of cancer immunosurveillance and immunoediting Immunity 21 137 148 10.1016/j.immuni.2004. 07.017 1:CAS:528:DC%2BD2cXnsVKltrY%3D 15308095 (Pubitemid 39094044)
10. JS Goodwin AD Bankhurst RP Messner 1977 Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell J Exp Med 146 1719 1734 10.1084/jem.146.6.1719 1:CAS:528: DyaE1cXksFeguw%3D%3D 411876
11. F Hirano K Kaneko H Tamura H Dong S Wang M Ichikawa C Rietz DB Flies JS Lau G Zhu K Tamada L Chen 2005 Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity Cancer Res 65 1089 1096 1:CAS:528:DC%2BD2MXhtVWnurg%3D 15705911
12. AL Hsu TT Ching DS Wang X Song VM Rangnekar CS Chen 2000 The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 J Biol Chem 275 11397 11403 10.1074/jbc.275.15.11397 1:CAS:528:DC%2BD3cXislShu70%3D 10753955 (Pubitemid 30212792)
13. M Huang M Stolina S Sharma JT Mao L Zhu PW Miller J Wollman H Herschman SM Dubinett 1998 Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production Cancer Res 58 1208 1216 1:CAS:528:DyaK1cXhvV2rs7w%3D 9515807
14. Y Iwai M Ishida Y Tanaka T Okazaki T Honjo N Minato 2002 Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Proc Natl Acad Sci USA 99 12293 12297 10.1073/pnas.192461099 1:CAS:528:DC%2BD38XntlCksL8%3D 12218188
15. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Pold M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S (2003) COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J, 03-0369fje
16. K Krysan KL Reckamp S Sharma SM Dubinett 2006 The potential and rationale for COX-2 inhibitors in lung cancer Anticancer Agents Med Chem 6 209 220 10.2174/187152006776930882 1:CAS:528:DC%2BD28XkvFKkur8%3D 16712449
17. S Le Bras I Foucault A Foussat C Brignone O Acuto M Deckert 2004 Recruitment of the actin-binding protein HIP-55 to the immunological synapse regulates T cell receptor signaling and endocytosis J Biol Chem 279 15550 15560 10.1074/jbc.M312659200 1:CAS:528:DC%2BD2cXivVKgt7k%3D 14729663 (Pubitemid 38618956)
18. DR Leach MF Krummel JP Allison 1996 Enhancement of antitumor immunity by CTLA-4 blockade Science 271 1734 1736 10.1126/science.271.5256.1734 1:CAS:528:DyaK28XhvVWmsLk%3D 8596936
19. J Liou F Kiefer A Dang A Hashimoto MH Cobb T Kurosaki A Weiss 2000 HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1 Immunity 12 399 408 10.1016/S1074-7613(00)80192-2 1:CAS:528:DC%2BD3cXivFyrsb0%3D 10795738
20. CH Liu SH Chang K Narko OC Trifan MT Wu E Smith C Haudenschild TF Lane T Hla 2001 Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice J Biol Chem 276 18563 18569 10.1074/jbc.M010787200 1:CAS:528:DC%2BD3MXktFWmtbc%3D 11278747
21. + T cells J Exp Med 204 879 891 10.1084/jem.20061699 1:CAS:528:DC%2BD2sXksFSqu74%3D 17403934 (Pubitemid 46631616)
22. GT Makoul DR Robinson AK Bhalla LH Glimcher 1985 Prostaglandin E2 inhibits the activation of cloned T cell hybridomas J Immunol 134 2645 2650 1:CAS:528:DyaL2MXhs1Wit74%3D 2857750
23. O Mandelboim G Berke M Fridkin M Feldman M Eisenstein L Eisenbach 1994 CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma Nature 369 67 71 10.1038/369067a0 1:STN:280:DyaK2c3hslyisw%3D%3D 8164742 (Pubitemid 24144356)
24. JL Masferrer KM Leahy AT Koki BS Zweifel SL Settle BM Woerner DA Edwards AG Flickinger RJ Moore K Seibert 2000 Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 1306 1311 1:CAS:528: DC%2BD3cXhvFWrt74%3D 10728691
25. DJ McConkey S Orrenius M Jondal 1990 Agents that elevate cAMP stimulate DNA fragmentation in thymocytes J Immunol 145 1227 1230 1:CAS:528: DyaK3cXlslSht78%3D 2166110
26. C Nataraj DW Thomas SL Tilley M Nguyen R Mannon BH Koller TM Coffman 2001 Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse J Clin Invest 108 1229 1235 1:CAS:528:DC%2BD3MXns1ChsLk%3D 11602631
27. M Negishi Y Sugimoto A Ichikawa 1995 Molecular mechanisms of diverse actions of prostanoid receptors Biochim Biophys Acta (BBA)-Lipids Lipid Metab 1259 109 119 10.1016/0005-2760(95)00146-4
28. F Paliogianni RL Kincaid DT Boumpas 1993 Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways J Exp Med 178 1813 1817 10.1084/jem.178.5.1813 1:CAS:528:DyaK3sXlvFKntbY%3D 7693857 (Pubitemid 23318463)
29. F Pica O Franzese C D'Onofrio E Bonmassar C Favalli E Garaci 1996 Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway J Pharmacol Exp Ther 277 1793 1800 1:CAS:528:DyaK28XjslGksrY%3D 8667251
30. SA Quezada KS Peggs MA Curran JP Allison 2006 CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells J Clin Invest 116 1935 1945 10.1172/JCI27745 1:CAS:528:DC%2BD28XmvV2lurw%3D 16778987 (Pubitemid 44033317)
31. RS Rappaport GR Dodge 1982 Prostaglandin E inhibits the production of human interleukin 2 J Exp Med 155 943 948 10.1084/jem.155.3.943 1:CAS:528:DyaL38XhtlKrtrw%3D 6977613
32. K Sauer J Liou SB Singh D Yablonski A Weiss RM Perlmutter 2001 Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes J Biol Chem 276 45207 45216 10.1074/jbc.M106811200 1:CAS:528:DC%2BD3MXovFensLY%3D 11487585
33. S Sawasdikosol S Pyarajan S Alzabin G Matejovic SJ Burakoff 2007 Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway J Biol Chem 282 34693 34699 10.1074/jbc.M707425200 1:CAS:528:DC%2BD2sXhtlCrtrjL 17895239 (Pubitemid 350232471)
34. S Sawasdikosol KM Russo SJ Burakoff 2003 Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription Blood 101 3687 3689 10.1182/blood-2002-07-2316 1:CAS:528:DC%2BD3sXjs1aqt7k%3D 12522005 (Pubitemid 36857960)
35. WE Scales SW Chensue I Otterness SL Kunkel 1989 Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity J Leukoc Biol 45 416 421 1:CAS:528:DyaL1MXktVWnt7s%3D 2651547
36. J Schulze-Luehrmann B Santner-Nanan MK Jha A Schimpl A Avots E Serfling 2002 Hematopoietic progenitor kinase 1 supports apoptosis of T lymphocytes Blood 100 954 960 10.1182/blood-2002-01-0089 1:CAS:528:DC%2BD38XlvVCltb4%3D 12130508 (Pubitemid 34832623)
37. S Sharma M Huang M Dohadwala M Pold RK Batra SM Dubinett 2003 Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer Methods Mol Med 75 723 736 1:CAS:528:DC%2BD38XovVWksb0%3D 12407775
38. JW Shui JS Boomer J Han J Xu GA Dement G Zhou TH Tan 2007 Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses Nat Immunol 8 84 91 10.1038/ni1416 1:CAS:528:DC%2BD28XhtlaqsL7P 17115060 (Pubitemid 46242362)
39. M Stolina S Sharma Y Lin M Dohadwala B Gardner J Luo L Zhu M Kronenberg PW Miller J Portanova JC Lee SM Dubinett 2000 Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis J Immunol 164 361 370 1:CAS:528:DC%2BD3cXisFSr 10605031
40. G Strassmann V Patil-Koota F Finkelman M Fong T Kambayashi 1994 Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2 J Exp Med 180 2365 2370 10.1084/jem.180.6.2365 1:CAS:528:DyaK2cXmsVKqtrk%3D 7525853 (Pubitemid 24351620)
41. K Suzuki T Tadakuma H Kizaki 1991 Modulation of thymocyte apoptosis by isoproterenol and prostaglandin E2 Cell Immunol 134 235 240 10.1016/0008- 8749(91)90346-D 1:CAS:528:DyaK3MXltFamtb4%3D 1849462
42. M Tsujii RN DuBois 1995 Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 493 501 10.1016/0092-8674(95)90127-2 1:CAS:528:DyaK2MXpt1Olt7w%3D 8521479
43. M Tsujii S Kawano S Tsuji H Sawaoka M Hori RN DuBois 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 705 716 10.1016/S0092-8674(00)81433-6 1:CAS:528:DyaK1cXjsl2ksbw%3D 9630216 (Pubitemid 28257578)